195 related articles for article (PubMed ID: 19408347)
1. The role of ADAMs in disease pathophysiology.
Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
Clin Chim Acta; 2009 May; 403(1-2):31-6. PubMed ID: 19408347
[TBL] [Abstract][Full Text] [Related]
2. Role of ADAMs in cancer formation and progression.
Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
Clin Cancer Res; 2009 Feb; 15(4):1140-4. PubMed ID: 19228719
[TBL] [Abstract][Full Text] [Related]
3. ADAMs family and relatives in cardiovascular physiology and pathology.
Zhang P; Shen M; Fernandez-Patron C; Kassiri Z
J Mol Cell Cardiol; 2016 Apr; 93():186-99. PubMed ID: 26522853
[TBL] [Abstract][Full Text] [Related]
4. The ADAM metalloproteinases.
Edwards DR; Handsley MM; Pennington CJ
Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
[TBL] [Abstract][Full Text] [Related]
5. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
6. The ADAMs family of proteases as targets for the treatment of cancer.
Mullooly M; McGowan PM; Crown J; Duffy MJ
Cancer Biol Ther; 2016 Aug; 17(8):870-80. PubMed ID: 27115328
[TBL] [Abstract][Full Text] [Related]
7. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T; Jorissen E; Reiss K; Hartmann D
Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
[TBL] [Abstract][Full Text] [Related]
8. Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system.
Hsia HE; Tüshaus J; Brummer T; Zheng Y; Scilabra SD; Lichtenthaler SF
Cell Mol Life Sci; 2019 Aug; 76(16):3055-3081. PubMed ID: 31236626
[TBL] [Abstract][Full Text] [Related]
9. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
[TBL] [Abstract][Full Text] [Related]
10. A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches.
van der Vorst EPC; Weber C; Donners MMPC
Thromb Haemost; 2018 Jul; 118(7):1167-1175. PubMed ID: 29874690
[TBL] [Abstract][Full Text] [Related]
11. The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?
Duffy MJ; Mullooly M; O'Donovan N; Sukor S; Crown J; Pierce A; McGowan PM
Clin Proteomics; 2011 Jun; 8(1):9. PubMed ID: 21906355
[TBL] [Abstract][Full Text] [Related]
12. Ectodomain shedding and ADAMs in development.
Weber S; Saftig P
Development; 2012 Oct; 139(20):3693-709. PubMed ID: 22991436
[TBL] [Abstract][Full Text] [Related]
13. The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions.
Reiss K; Saftig P
Semin Cell Dev Biol; 2009 Apr; 20(2):126-37. PubMed ID: 19049889
[TBL] [Abstract][Full Text] [Related]
14. ADAM protein family - its role in tumorigenesis, mechanisms of chemoresistance and potential as diagnostic and prognostic factors.
Zadka L; Kulus MJ; Piatek K
Neoplasma; 2018 Nov; 65(6):823-839. PubMed ID: 30334448
[TBL] [Abstract][Full Text] [Related]
15. ADAM proteins - therapeutic potential in cancer.
Lu X; Lu D; Scully M; Kakkar V
Curr Cancer Drug Targets; 2008 Dec; 8(8):720-32. PubMed ID: 19075595
[TBL] [Abstract][Full Text] [Related]
16. ADAM Proteases and Gastrointestinal Function.
Jones JC; Rustagi S; Dempsey PJ
Annu Rev Physiol; 2016; 78():243-76. PubMed ID: 26667078
[TBL] [Abstract][Full Text] [Related]
17. Preferred SH3 domain partners of ADAM metalloproteases include shared and ADAM-specific SH3 interactions.
Kleino I; Järviluoma A; Hepojoki J; Huovila AP; Saksela K
PLoS One; 2015; 10(3):e0121301. PubMed ID: 25825872
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
[TBL] [Abstract][Full Text] [Related]
19. Necroptosis, ADAM proteases and intestinal (dys)function.
Heib M; Rose-John S; Adam D
Int Rev Cell Mol Biol; 2020; 353():83-152. PubMed ID: 32381179
[TBL] [Abstract][Full Text] [Related]
20. Multiple non-catalytic ADAMs are novel integrin α4 ligands.
Wang L; Hoggard JA; Korleski ED; Long GV; Ree BC; Hensley K; Bond SR; Wolfsberg TG; Chen J; Zeczycki TN; Bridges LC
Mol Cell Biochem; 2018 May; 442(1-2):29-38. PubMed ID: 28913673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
